Potent P2Y12 inhibitors versus clopidogrel in cancer patients undergoing percutaneous coronary intervention
{{output}}
Background: Patients with cancer undergoing percutaneous coronary intervention (PCI) experience higher risk of both ischemic and bleeding events. The aim of this study is to assess ischemic and bleeding risks after PCI in cancer ... ...
